Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome

• Main Authors: Rena Eudy‐Byrne (Author), Nicole Zane (Author), Susan C. Adeniyi‐Jones (Author), Marc R. Gastonguay (Author), Ana Ruiz‐Garcia (Author), Gagan Kaushal (Author), Walter K. Kraft (Author)
• Format: Book
• Published: Wiley, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Results from Blinded Buprenorphine OR Neonatal morphine solution (BBORN), a previous phase III trial in infants with neonatal opioid withdrawal syndrome (NOWS), demonstrated that sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than th...